Dillard'S (DDS) Cash & Equivalents (2009 - 2026)

Dillard'S (DDS) has 18 years of Cash & Equivalents data on file, last reported at $861.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 20.0% year-over-year to $861.5 million; the trailing twelve-month figure through Jan 2026 stood at $861.5 million (up 20.0% YoY), and the FY2026 full-year result was $861.5 million, up 20.0% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $861.5 million, down from $1.1 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.1 billion in Q4 2025 and bottomed at $492.9 million in Q3 2022.
• The 5-year median for Cash & Equivalents is $842.0 million (2023), against an average of $818.5 million.
• Peak annual rise in Cash & Equivalents reached 98.91% in 2022, while the deepest fall reached 26.38% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $532.7 million in 2022, then jumped by 58.06% to $842.0 million in 2023, then climbed by 16.44% to $980.4 million in 2024, then climbed by 17.22% to $1.1 billion in 2025, then decreased by 25.04% to $861.5 million in 2026.
• The last three Cash & Equivalents figures came in at $861.5 million (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison